Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion.
about
The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factorBone morphogenetic proteins and bone morphogenetic protein gene therapy in neurological surgery: a review.Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents.Evaluation of dense polylactic acid/beta-tricalcium phosphate scaffolds for bone tissue engineering.Clinical and radiological outcomes of a new cage for direct lateral lumbar interbody fusionFGF2 gene activated matrices promote proliferation of bone marrow stromal cellsSpinal fusion using an autologous growth factor gel and a porous resorbable ceramic.A comparative evaluation of factors influencing osteoinductivity among scaffolds designed for bone regenerationSustained release of bone morphogenetic protein 2 via coacervate improves the osteogenic potential of muscle-derived stem cells.Humoral bone morphogenetic protein 2 is sufficient for inducing breast cancer microcalcification.In vitro and in vivo evaluations on osteogenesis and biodegradability of a β-tricalcium phosphate coated magnesium alloy.Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: a comparison of rhBMP-2, cancellous bone graft, and absorbable collagen sponge.Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4).Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2.Polyhedral microcrystals encapsulating bone morphogenetic protein 2 improve healing in the alveolar ridge.
P2860
Q24631224-B980535C-1CF0-4B8A-A4B1-B811ECA357D7Q30305648-41151993-62CC-4501-9644-BA148F67B3D6Q30310132-E3204E19-F2B7-4460-9833-28F0C3A79C8FQ34217646-4C68004D-8503-47CB-9924-545A24BF79A3Q34391008-C9816F59-2D75-416B-BF81-6473D5B2FFCEQ36259512-959692E0-B7E5-4656-89E2-A1ABA898F625Q36307961-63FF48E5-B573-4F59-848D-6E19E38BD9FFQ36977603-D0334DF8-FBD0-4D83-A95E-CF0C35B25217Q37124556-710412B5-1104-4D52-894C-EFE855EF5579Q37400376-35DB0997-2A4F-435B-B0AA-1C28C1E2D1A0Q39449348-E23D7C7F-6B8C-4537-9A1D-4AD322DEA40BQ43603744-104A5DFE-B0D9-435C-9B18-32EB5239A8B8Q45880508-EC96F559-9260-4C31-A5D8-752E8F0CE166Q45963541-666C5862-863A-4650-A9F0-73FCDD551908Q52795553-7D34F3B8-CD3F-4506-9D99-DF070C5B8026
P2860
Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@ast
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@en
type
label
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@ast
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@en
prefLabel
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@ast
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@en
P2093
P1476
Utilization of type I collagen ...... ous bone lumbar spinal fusion.
@en
P2093
Gillies GT
Jane JA Jr
Kallmes DF
Sheehan JM
Sheehan JP
Simmons NE
Sweeney TM
diPierro CG
P304
P356
10.3171/JNS.1997.86.1.0093
P577
1997-01-01T00:00:00Z